Literature DB >> 26740457

The expanding repertoire of receptor activity modifying protein (RAMP) function.

Klara R Klein1, Brooke C Matson1, Kathleen M Caron1,2.   

Abstract

Receptor activity modifying proteins (RAMPs) associate with G-protein-coupled receptors (GPCRs) at the plasma membrane and together bind a variety of peptide ligands, serving as a communication interface between the extracellular and intracellular environments. The collection of RAMP-interacting GPCRs continues to expand and now consists of GPCRs from families A, B and C, suggesting that RAMP activity is extremely prevalent. RAMP association with GPCRs can regulate GPCR function by altering ligand binding, receptor trafficking and desensitization, and downstream signaling pathways. Here, we elaborate on these RAMP-dependent mechanisms of GPCR regulation, which provide opportunities for pharmacological intervention.

Entities:  

Keywords:  CLR; G-protein; GPCR; desensitization; ligand; signaling; trafficking

Mesh:

Substances:

Year:  2016        PMID: 26740457      PMCID: PMC4911013          DOI: 10.3109/10409238.2015.1128875

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  54 in total

1.  Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.

Authors:  Jennifer M Bomberger; Narayanan Parameswaran; Carolyn S Hall; Nambi Aiyar; William S Spielman
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

Review 2.  Understanding RAMPs through genetically engineered mouse models.

Authors:  Mahita Kadmiel; Kimberly L Fritz-Six; Kathleen M Caron
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction.

Authors:  Sophocles Chrissobolis; Zhongming Zhang; Dale A Kinzenbaw; Cynthia M Lynch; Andrew F Russo; Frank M Faraci
Journal:  Stroke       Date:  2010-09-02       Impact factor: 7.914

4.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

5.  An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.

Authors:  R Muff; N Bühlmann; J A Fischer; W Born
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

Review 6.  Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes.

Authors:  Roman Muff; Walter Born; Thomas A Lutz; Jan A Fischer
Journal:  Peptides       Date:  2004-11       Impact factor: 3.750

7.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

8.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

9.  Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2).

Authors:  Cathryn Weston; Jing Lu; Naichang Li; Kerry Barkan; Gareth O Richards; David J Roberts; Timothy M Skerry; David Poyner; Meenakshi Pardamwar; Christopher A Reynolds; Simon J Dowell; Gary B Willars; Graham Ladds
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

10.  TreeFam: 2008 Update.

Authors:  Jue Ruan; Heng Li; Zhongzhong Chen; Avril Coghlan; Lachlan James M Coin; Yiran Guo; Jean-Karim Hériché; Yafeng Hu; Karsten Kristiansen; Ruiqiang Li; Tao Liu; Alan Moses; Junjie Qin; Søren Vang; Albert J Vilella; Abel Ureta-Vidal; Lars Bolund; Jun Wang; Richard Durbin
Journal:  Nucleic Acids Res       Date:  2007-12-01       Impact factor: 16.971

View more
  15 in total

1.  CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.

Authors:  Keegan J Bohn; Baolin Li; Xiaofang Huang; Bianca N Mason; Anne-Sophie Wattiez; Adisa Kuburas; Christopher S Walker; Peiyi Yang; Jianliang Yu; Beverly A Heinz; Kirk W Johnson; Andrew F Russo
Journal:  Br J Pharmacol       Date:  2017-04-22       Impact factor: 8.739

Review 2.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

3.  RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis.

Authors:  Duncan I Mackie; Natalie R Nielsen; Matthew Harris; Smriti Singh; Reema B Davis; Danica Dy; Graham Ladds; Kathleen M Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

Review 4.  Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.

Authors:  G R Kolar; S M Grote; G L C Yosten
Journal:  J Intern Med       Date:  2016-06-16       Impact factor: 8.989

Review 5.  Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.

Authors:  Denise Wootten; Laurence J Miller
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-08-27       Impact factor: 13.820

Review 6.  Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.

Authors:  Henry A Dunn; Cesare Orlandi; Kirill A Martemyanov
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

7.  Fluid intake, what's dopamine got to do with it?

Authors:  Elizabeth G Mietlicki-Baase; Jessica Santollo; Derek Daniels
Journal:  Physiol Behav       Date:  2021-04-07

Review 8.  Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.

Authors:  Abimael González-Hernández; Bruno A Marichal-Cancino; Jair Lozano-Cuenca; Jorge S López-Canales; Enriqueta Muñoz-Islas; Martha B Ramírez-Rosas; Carlos M Villalón
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

9.  CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells.

Authors:  Ashley J Clark; Niamh Mullooly; Dewi Safitri; Matthew Harris; Tessa de Vries; Antoinette MaassenVanDenBrink; David R Poyner; Davide Gianni; Mark Wigglesworth; Graham Ladds
Journal:  Commun Biol       Date:  2021-06-23

10.  Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation.

Authors:  Mahita Kadmiel; Brooke C Matson; Scott T Espenschied; Patricia M Lenhart; Kathleen M Caron
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.